Regulations and Regulatory Advocacy
A hospital鈥檚 penalty status in the Centers for Medicare & Medicaid Services鈥 Hospital-Acquired Conditions Reduction Program is heavily influenced by chance.
AHA comments to the Office of the National Coordinator for Health Information on its draft Trusted Exchange Framework and Common Agreement as well as ONC鈥檚 draft U.S. Core Data for Interoperability document.
The Drug Enforcement Administration will focus over the next 45 days on pharmacies and prescribers who are dispensing 鈥渦nusual or disproportionate amounts鈥 of prescription opioid drugs.
The 黑料正能量 Association today released a new analysis showing that providers spend nearly $39 billion a year solely on administrative activities related to regulatory compliance.
Every day, hospitals, health systems and post-acute care providers confront the daunting task of complying with a growing number of federal regulations. They are constantly challenged to understand and implement new or revised regulations, while maintaining their core mission of providing high-鈥
Todays rule outlines some promising proposals intended to reduce regulatory barriers for hospitals, health systems and the patients they serve.
The regulatory burden that is imposed on hospitals and health systems is substantial and unsustainable, and has grown in recent years. We are encouraged by the executive order signed by President Trump today that will help reduce red tape.
CMS today finalized new and expanded mandatory bundled payment models in an effort to coordinate patient care across the health care continuum, something Americas hospitals are already doing to better serve patients and improve care quality.
AHA urges the Centers for Medicare & Medicaid Services (CMS) to issue an Interim Final Rule (IFR) with comment period requiring that qualified health plans (QHPs) offered through the Health Insurance Marketplaces accept third-party premium and cost-sharing payments from hospitals, hospital-鈥
We support FDA鈥檚 efforts to improve the safety and efficacy of POC BGMS used for hospitalized patients. However, we are concerned that, as written, the draft guidance would have serious unintended consequences for patients and hospitals, including placing patients at unnecessary risk.